Harpoon cuts bait with lead program after failing to find silver linings from ASCO data, other studies
Harpoon’s recent slide continued Thursday as it axed its lead program.
With market cap bleeding since June and a CEO resignation last October, Harpoon announced …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.